Ascendis Pharma A/S Overview
Ascendis Pharma A/S Target Price
Analysts' 12-month price predictions for ASND.
Get informed when a big investor buys or sells
+ FollowShare Price
$274.5
Average Target Price
$318.80
16.1% upside
16.1% upside5 analysts in the last 4 months
High: $345 | Low: $262
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-15 | Evercore ISI | $329 | 19.9% upside |  |
| 2026-05-11 | Barclays | $345 | 25.7% upside | |
| 2026-05-08 | Wells Fargo | $326 | 18.8% upside | |
| 2026-03-05 | Jefferies | $262 |  4.6% downside | |
| 2026-03-04 | Stifel NicolausAlex Thompson | $332 | 20.9% upside | |
| 2026-03-02 | Wolfe ResearchKalpit Patel | $260 | 5.3% downside | |
| 2026-03-02 | Cantor FitzgeraldLi Watsek | $300 | 9.3% upside | |
| 2026-03-02 | Evercore ISIJosh Schimmer | $324 | 18% upside | |
| 2026-03-02 | Goldman SachsPaul Choi | $255 | 7.1% downside | |
| 2026-02-12 | Wedbush | $273 | 0.5% downside | |
| 2026-02-12 | Oppenheimer | $262 | 4.6% downside | |
| 2026-02-12 | Stifel NicolausAlex Thompson | $325 | 18.4% upside | |
| 2026-02-12 | Morgan StanleyMaxwell Skor | $256 | 6.7% downside | |
| 2026-01-27 | BarclaysEliana Merle | $342 | 24.6% upside | |
| 2026-01-20 | RBC Capital | $250 | 8.9% downside | |
| 2026-01-20 | Wells FargoDerek Archila | $330 | 20.2% upside | |
| 2026-01-09 | Wells Fargo | $322 | 17.3% upside | |
| 2025-12-11 | Stifel NicolausAlex Thompson | $256 | 6.7% downside | |
| 2025-10-13 | Cantor FitzgeraldLi Watsek | $254 | 7.5% downside | |
| 2025-08-08 | RBC CapitalLuca Issi | $230 | 16.2% downside | |
| 2025-02-18 | Morgan Stanley | $180 | 34.4% downside | |
| 2024-09-23 | Bank of America SecuritiesTazeen Ahmad | $191 | 30.4% downside | |
| 2024-09-17 | Evercore ISIGavin Clark-Gartner | $205 | 25.3% downside | |
| 2024-09-17 | OppenheimerLeland Gershell | $190 | 30.8% downside | |
| 2024-09-17 | CitigroupDavid Lebowitz | $207 | 24.6% downside | |
| 2024-09-17 | Wells FargoDerek Archila | $289 | 5.3% upside | |
| 2024-09-16 | Bank of America SecuritiesTazeen Ahmad | $175 | 36.2% downside | |
| 2024-09-16 | Goldman SachsPaul Choi | $200 | 27.1% downside | |
| 2024-09-13 | CitigroupDavid Lebowitz | $178 | 35.2% downside | |
| 2024-09-05 | OppenheimerLeland Gershell | $180 | 34.4% downside | |
| 2024-08-13 | JefferiesKelly Shi | $196 | 28.6% downside | |
| 2024-05-30 | Stifel NicolausAlex Thompson | $200 | 27.1% downside | |
| 2024-05-15 | Morgan StanleyVikram Purohit | $140 | 49% downside | |
| 2024-03-14 | Evercore ISIJosh Schimmer | $191 | 30.4% downside | |
| 2023-01-03 | Wells Fargo | $177 | 35.5% downside | |
| 2022-11-15 | Morgan Stanley | $148 | 46.1% downside | |
| 2022-11-14 | Leerink Partners | $148 | 46.1% downside | |
| 2022-11-14 | Wedbush | $164 | 40.3% downside | |
| 2022-03-20 | Bank of America SecuritiesTazeen Ahmad | $161 | 41.3% downside | |
| 2022-02-28 | CitigroupDavid Lebovitz | $187 | 31.9% downside | |
| 2022-01-06 | Cowen & Co.Yaron Werber | $136 | 50.5% downside | |
| 2021-07-07 | Canaccord GenuityMichelle Gilson | $196 | 28.6% downside | |
| 2021-06-14 | Cantor FitzgeraldAlethia Young | $201 | 26.8% downside | |